Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Court Allows New Trial in Hormone Therapy Case
NY Times, NY
Monday, June 21, 2010 - 12:04pm
tags:
HRT, Wyeth, Pfizer, breast cancer, Supreme Court
FDA grants approval for APP Pharmaceuticals drug
Yahoo/AP
Monday, June 21, 2010 - 10:31am
tags:
FDA, generics, APP, aztreonam, anti-infectives, Azactam, Bristol-Myers Squibb
Affymax Shares Fall on Hematide Drug’s Safety Concern
Bloomberg
Monday, June 21, 2010 - 10:27am
tags:
anemia, Affymax, Hematide
AstraZeneca's $103M Drug Pricing Settlement Is Merely Tip of the Over-Charging Iceberg
BNET Pharma
Monday, June 21, 2010 - 10:24am
tags:
AstraZeneca, settlements, drug pricing, Medicare fraud
Charles River Laboratories, WuXi PharmaTech: A Little Medicine for a Big Pharma Deal
Seeking Alpha
Monday, June 21, 2010 - 10:23am
tags:
Charles River Laboratories, WuXi PharmaTech, M&A
Do The Quants Have It In For Pfizer?
Forbes
Monday, June 21, 2010 - 9:43am
tags:
Pfizer, investors, quants
Boehringer Heart Drug Fails To Beat Aspirin
Pharmalot
Monday, June 21, 2010 - 9:41am
tags:
aspirin, Boehringer Ingelheim, Aggrenox, stroke
Myriad Pharmaceuticals: A Value Investor's Dream
Seeking Alpha
Monday, June 21, 2010 - 9:39am
tags:
Myriad
Valeant, Canada’s Biovail to Combine in Stock Deal
Bloomberg
Monday, June 21, 2010 - 9:34am
tags:
Valeant Pharmaceuticals, Canada, M&A, Biovail
The Market Is Wrong About Vanda
Seeking Alpha
Monday, June 21, 2010 - 9:24am
tags:
Vanda, Fanapt, schizophrenia
Exelixis regains rights to a cancer drug from BMY
Marketwatch
Monday, June 21, 2010 - 9:19am
tags:
Exelixis, Bristol-Myers Squibb, cancer
FDA panel approves rival to Teva's Plan contraceptive B
Globes, Israel
Sunday, June 20, 2010 - 11:26am
tags:
FDA, Teva Pharmaceuticals, Plan B contraceptive, ellaOne
Pfizer Faces Trials in 200 Suits Over Hormone-Drugs
Bloomberg
Sunday, June 20, 2010 - 11:23am
tags:
lawsuits, Pfizer, Wyeth, Prempro, HRT
Life Sciences Companies Capture the Cash
Seeking Alpha
Sunday, June 20, 2010 - 11:21am
tags:
Abbott Laboratories, Aeterna Zentaris, Bayer, Celsion, Cytori, Genzyme, Discovery Labs, GTC Biotherapeutics, Gen-Probe, Neurocrine, Pharmacyclics, Teva Pharmaceuticals, ProUroCare, SafeStitch Medical
Cypress Bioscience In-Licenses BioLineRx's Novel Antipsychotic
Yahoo
Sunday, June 20, 2010 - 11:17am
tags:
licensing, Cypress Bioscience, BioLineRx, antipsychotics
King Pharmaceuticals: Looking Ahead to the June 2010 Quarter
Seeking Alpha
Sunday, June 20, 2010 - 11:14am
tags:
King
Choose China Pharmaceutical?: China Watch Mail Bag (Video)
The Street
Saturday, June 19, 2010 - 1:06pm
tags:
China Pharmaceutical
Russia to spend $4 bln on pharma industry by 2020
Economic Times, India
Saturday, June 19, 2010 - 1:01pm
tags:
Russia
Global pharma eyes Russia riches with local presence
Money Control
Saturday, June 19, 2010 - 12:58pm
tags:
investors
Amylin Soars on Roche’s Diabetes Delay
Barron's
Saturday, June 19, 2010 - 12:55pm
tags:
Amylin, Roche, type 2 diabetes, Bydureon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.